Perspectives on hemorrhoids and their management among gastroenterologists across India: findings from in-clinic questionnaire-based survey studies

Harshad  Khairnar; Kunal J. Khobragade; Nilesh E. Borkar

doi:10.18203/2394-6040.ijcmph20253259

Authors

Harshad Khairnar Department Gastroenterology, Digest the Gut and Liver Clinic. Seawoods, Navi Mumbai India
Kunal J. Khobragade Department of Mankind Pharma Ltd., Seawoods Grand Central, Seawoods, Nerul Node, Navi Mumbai, India
Nilesh E. Borkar Department of Mankind Pharma Ltd., Seawoods Grand Central, Seawoods, Nerul Node, Navi Mumbai, India

DOI:

https://doi.org/10.18203/2394-6040.ijcmph20253259

Keywords:

Calcium dobesilate, Euphorbia prostrata, Euphorbia prostrata plus, Hemorrhoids, Cancer survey

Abstract

Background: Hemorrhoids are associated with bleeding, pain, itching, exudation and swelling with a high increasing prevalence, hence the current survey was designed to assess the real-world perspectives of demographic characteristics and practical approaches utilized by Gastroenterologists in managing hemorrhoids and bleeding hemorrhoids with a focus on Euphorbia prostrata (EP) and its combinations.

Methods: Two real-world in-clinic observational surveys, which utilized digitally enabled questionnaires for data collection, were conducted between January and March 2023 and July and September 2023, involving 325 Gastroenterologists from various regions of India.

Results: 40% of gastroenterologists managed 10 to 20 cases of bleeding hemorrhoids per month, while the patients suffering from various grades of hemorrhoids were Grade 1 (25%), Grade 2 (45%), Grade 3 (20%) & Grade 4 (10%), with bleeding (85%), pain (82%) as major sign and symptoms. In bleeding hemorrhoids, the thrombosed complication was higher, i.e., 59.75%, as compared to hemorrhoids patients. The notable role of EP was reduction in 67% bleeding, 57% pain with wound healing in 78% of patients. Further in bleeding hemorrhoids combination of flavonoids plus calcium dobesilate was most preferred (96.28%), which corelated to the usage of EP plus calcium dobesilate in clinical practice with its high effectiveness (73.07%) in bleeding hemorrhoids.

Conclusions: Hemorrhoids are the most prevalent diagnosis among patients treated by Gastroentrologist. EP is the most commonly used drug for the treatment of hemorrhoids, while EP plus calcium dobesilate, being the preferred combination in management of bleeding hemorrhoids.

Metrics

Metrics Loading ...

References

Sun Z, Migaly J. Review of Hemorrhoid Disease: Presentation and Management. Clin Colon Rectal Surg. 2016;29(1):22-9. DOI: https://doi.org/10.1055/s-0035-1568144

Shinde P, Chawada M, Deshmukh S. A study of surgical profile of patients with hemorrhoids at a tertiary care hospital. International Surgery Journal. 2019;6:916. DOI: https://doi.org/10.18203/2349-2902.isj20190824

Al-Masoudi RO, Shosho R, Alquhra D. Prevalence of Hemorrhoids and the Associated Risk Factors Among the General Adult Population in Makkah, Saudi Arabia. Cureus. 2024;16(1):98. DOI: https://doi.org/10.7759/cureus.51612

Lohsiriwat V. Hemorrhoids: From basic pathophysiology to clinical management. World J Gastroenterol. 2012;18(17):2009-17. DOI: https://doi.org/10.3748/wjg.v18.i17.2009

Alonso‐Coello P, Guyatt GH, Heels‐Ansdell D. Laxatives for the treatment of hemorrhoids. Cochrane Database Syst Rev. 2005;2005(4):4649. DOI: https://doi.org/10.1002/14651858.CD004649.pub2

Sheikh P, Lohsiriwat V, Shelygin Y. Micronized Purified Flavonoid Fraction in Hemorrhoid Disease: A Systematic Review and Meta-Analysis. Adv Ther. 2020;37(6):2792-812. DOI: https://doi.org/10.1007/s12325-020-01353-7

Shanmugam V, Hakeem A, Campbell KL. Rubber band ligation versus excisional haemorrhoidectomy for haemorrhoids. Cochrane Database Syst Rev. 2005;2005(1):5034. DOI: https://doi.org/10.1002/14651858.CD005034

Porwal A, Gandhi P, Mokashi-Bhalerao N, Borkar N, Khobragade K. Efficacy and safety of oral euphorbia prostrata tablet and topical cream in the management of hemorrhoids during pregnancy: results from a prospective multicenter study. Cureus. 2012;16(2):54152.

The efficacy of Euphorbia prostrata in early grades. Avaialble at: https://www.europeanreview.org/wp/wp. Accessed on 21 June 2025.

La Torre F, Nicolai AP. Clinical use of micronized purified flavonoid fraction for treatment of symptoms after hemorrhoidectomy: results of a randomized, controlled, clinical trial. Dis Colon Rectum. 2004;47(5):704-10. DOI: https://doi.org/10.1007/s10350-003-0119-1

Gupta PJ. The efficacy of Euphorbia prostrata in early grades of symptomatic hemorrhoids–a pilot study. European Rev Med Pharmacol Sci. 2011;15(2):578.

Razdar S, Panahi Y, Mohammadi R, Khedmat L, Khedmat H. Evaluation of the efficacy and safety of an innovative flavonoid lotion in patients with haemorrhoid: a randomised clinical trial. BMJ Open Gastroenterol. 2023;10(1):1158. DOI: https://doi.org/10.1136/bmjgast-2023-001158

Khobragade K, C. S. Patil, Borkar NE. Clinical Efficacy of Concurrent Therapy with Oral FDC Tablet of Euphorbia prostrataplus Calcium Dobesilate and Topical FDC Cream of Euphorbia prostrataplus Lidocaine in the Management of Haemorrhoids: A Prospective, Open-Labeled Multicentric Study. International Journal Of Medical And Health Sciences. 2019;8(4):63-71.

Bakhshi GD, Langade DG, Desai VS. Prospective, open label study of Euphorbia prostrata extract 100 mg in the treatment of bleeding haemorrhoids. Bombay Hosp J. 2008;50(4):577-83.